Seminars

CNME sponsors a seminar series each year to expose trainees to cutting edge research in nanotechnology for the delivery of drugs, biological molecules, and diagnostic agents. The series is available as a for-credit course for UCSD graduate and pharmacy students and advertised across relevant departments. CNME seminars are held on Wednesdays at noon in PSB 1120 during the spring quarter.

2015 series: Grand medical challenges

• April 1- Willem Mulder, Mt. Sinai School of Medicine, “Cardiovascular nanomedicine: a small solution to a big problem”
• April 8- Fatta Nahab,University of California, San Diego, “Challenges in diagnosing and treatingneurodegenerative diseases of the brain”
• April 15- John Glass, J. Craig Venter Institute, “Rapid vaccine generation via synthetic genomics”
• April 22- Jane Kim, University of California, San Diego, “Pediatric diabetes detection and management: possibilities for innovation”
• April 29- Dai Fukumura, Harvard Medical School, “Understanding tumor angiogenesis to improve cancer nanomedicine”
• May 6- Basilia Zingarelli, Cincinnati Children’s Hospital, “Unmet needs in intensive care for sepsis and hemorrhagic shock”
• May 13- Chad Cowan, Harvard University and Massachusetts General Hospital, “Genome editing: from modeling disease to novel therapeutics”
• May 20- Lingyun Cheng, Universityof California, San Diego, “Novel drug delivery strategies for refractory vitreoretinal diseases”
• May 27- Aydogan Ozcan, University of California, Los Angeles, “Diagnostics for low-resource settings”
• June 3- Peter Attia, Nutrition Science Initiative, “New directions for metabolic disease prevention and early detection”

​Special seminar: Innovation and entrepreneurship in the medical device industry

Peter Farrell, founder and chairman of the board of ResMed, Inc., a producer of medical equipment to treat, diagnose, and manage sleep-disordered breathing and other respiratory disorders, visited UC San Diego in June 2014 to share his perspective on fostering the development of new technologies likely to impact the clinic and biotech market.

2014 series: Clinically promising technologies

• April 2- Jeremy Heidel, Arrowhead Research
• April 9- Andrew Tsourkas, University of Pennsylvania
• April 16- Michael Davis, Georgia Tech and Emory University
• April 23- Alysson Muotri, UC San Diego
• April 30- Jeff Hrkach, BIND Therapeutics
• May 7- Shanta Dhar, University of Georgia
• May 14- Jeff Karp, Brigham and Women’s Hospital and Harvard Medical School
• May 21- Erin Lavik, Case Western Reserve University—CANCELLED; will reschedule
• May 28- Steve Little, University of Pittsburgh
• June 4- Todd Harris, Sienna Labs

Sign up here using a .edu email address if you’d like to receive updates about future CNME seminars. Videos of many 2012 seminars are available here; request the password from Jessica Moore at j1moore@ucsd.edu. If the login window does not appear, try accessing it with a different browser.